NMC Health Plc - Grant of Options
Grant of options
These awards, by way if nil-cost options, were made to Directors and PDMRs of the Company as follows:
|
|
Director / PDMR |
Number of shares subject to award |
|
|
Director |
73,425 |
|
|
Director |
43,846 |
|
Hani Buttikhi |
Director |
32,369 |
|
|
PDMR |
26,003 |
|
|
PDMR |
19,502 |
|
Dr. Chandrakumari Shetty |
PDMR |
26,913 |
|
|
PDMR |
15,480 |
The vesting of all the awards granted under the LTIP referred to above are subject to the achievement of performance targets relating to the Company's EBITDA growth and total shareholder return (relative to a comparator group) over a three-year performance period.
In addition, the vesting of all the awards granted will be subject to performance against an additional underpin capturing the conversion of EBITDA to net income to provide shareholders with an aggregate view on earnings, cash flow, and capital efficiency. Failure to meet the underpin will reduce the proportion of these LTIP awards vesting by 50%. The awards are also granted subject to an additional holding period of two years applying after any vesting of the awards during which award holders cannot exercise vested awards.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
|
Mr Mr Mr Hani Buttikhi Mr Mr Dr Chandrakumari Shetty Mr |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Directors and PDMRs of the Company |
|
b)
|
Initial notification /Amendment |
Initial notification |
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
|
|
|
b) |
LEI |
2138008YQEVWBE1V2M52 |
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares
ISIN: GB00B7FC0762 |
|
b) |
Nature of the transaction |
Grant of nil-cost options
|
||||||||||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||||||||||
|
d) |
Aggregated information - volume - Price - Total |
N/A
|
||||||||||||||||
|
e) |
Date of the transaction |
|
||||||||||||||||
|
f) |
Place of the transaction |
Not on a trading venue |
Contacts
|
NMC |
|
|
|
+44 (0)20 3205 7313 |
|
|
|
|
Media |
|
|
FTI Consulting, |
|
|
|
+44 (0)20 3727 1100 |
|
|
|
|
FTI Consulting, Gulf |
|
|
|
+971 (0)4 437 2100 |
This information is provided by RNS, the news service of the
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE